Clinical trial
Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South…
NCT00255840 · CIPRA SA, Other · Completed
Key facts
| NCT number | NCT00255840 |
|---|---|
| Title | Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities |
| Official title | "Safeguard the Household" - A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country |
| Lead sponsor | CIPRA SA, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral, Drug |
| Interventions | Monitoring by an HIV-trained medical doctor, Monitoring by an HIV-trained primary care nurse, Efavirenz, Lamivudine, Lopinavir/Ritonavir, Nevirapine, Stavudine |
| Enrollment | 812 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Nov 21, 2005 |
| Last update posted | Jun 21, 2011 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: